Development of Kawasaki disease in a patient with PFAPA

Takahito Ninomiya, Hidetoshi Takada, Yusaku Nagatomo, Etsuro Nanishi, Hazumu Nagata, Kenichiro Yamamura, Takehiko Doi, Kazuyuki Ikeda, Toshiro Hara

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA) is one of the autoinflammatory diseases of unknown etiology characterized by regularly recurrent fever episodes with attacks lasting 3-6 days every 3-8 weeks associated with at least one of the three cardinal clinical signs: aphthous stomatitis, pharyngitis, and cervical adenitis. Kawasaki disease (KD) is an acute, self-limited systemic vasculitis that occurs predominantly in infants and young children. In most KD patients, i.v. immunoglobulin leads to a rapid amelioration of clinical symptoms and significantly decreases the risk of coronary artery aneurysms. Although the etiology of KD is still unknown, it was reported that innate immunity was activated in the patients. Described herein is a patient with PFAPA who developed KD. This is the first report of KD development in a PFAPA patient. The association between KD and PFAPA may represent a genetic predisposition to dysregulated innate immune response.

Original languageEnglish
Pages (from-to)801-802
Number of pages2
JournalPediatrics International
Volume55
Issue number6
DOIs
Publication statusPublished - Jan 1 2013

Fingerprint

Mucocutaneous Lymph Node Syndrome
Aphthous Stomatitis
Lymphadenitis
Pharyngitis
Innate Immunity
Fever
Coronary Aneurysm
Systemic Vasculitis
Genetic Predisposition to Disease
Immunoglobulins
Coronary Vessels

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

Cite this

Ninomiya, T., Takada, H., Nagatomo, Y., Nanishi, E., Nagata, H., Yamamura, K., ... Hara, T. (2013). Development of Kawasaki disease in a patient with PFAPA. Pediatrics International, 55(6), 801-802. https://doi.org/10.1111/ped.12225

Development of Kawasaki disease in a patient with PFAPA. / Ninomiya, Takahito; Takada, Hidetoshi; Nagatomo, Yusaku; Nanishi, Etsuro; Nagata, Hazumu; Yamamura, Kenichiro; Doi, Takehiko; Ikeda, Kazuyuki; Hara, Toshiro.

In: Pediatrics International, Vol. 55, No. 6, 01.01.2013, p. 801-802.

Research output: Contribution to journalArticle

Ninomiya, T, Takada, H, Nagatomo, Y, Nanishi, E, Nagata, H, Yamamura, K, Doi, T, Ikeda, K & Hara, T 2013, 'Development of Kawasaki disease in a patient with PFAPA', Pediatrics International, vol. 55, no. 6, pp. 801-802. https://doi.org/10.1111/ped.12225
Ninomiya, Takahito ; Takada, Hidetoshi ; Nagatomo, Yusaku ; Nanishi, Etsuro ; Nagata, Hazumu ; Yamamura, Kenichiro ; Doi, Takehiko ; Ikeda, Kazuyuki ; Hara, Toshiro. / Development of Kawasaki disease in a patient with PFAPA. In: Pediatrics International. 2013 ; Vol. 55, No. 6. pp. 801-802.
@article{04e72624b6c3484cb8f1802622379346,
title = "Development of Kawasaki disease in a patient with PFAPA",
abstract = "Periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA) is one of the autoinflammatory diseases of unknown etiology characterized by regularly recurrent fever episodes with attacks lasting 3-6 days every 3-8 weeks associated with at least one of the three cardinal clinical signs: aphthous stomatitis, pharyngitis, and cervical adenitis. Kawasaki disease (KD) is an acute, self-limited systemic vasculitis that occurs predominantly in infants and young children. In most KD patients, i.v. immunoglobulin leads to a rapid amelioration of clinical symptoms and significantly decreases the risk of coronary artery aneurysms. Although the etiology of KD is still unknown, it was reported that innate immunity was activated in the patients. Described herein is a patient with PFAPA who developed KD. This is the first report of KD development in a PFAPA patient. The association between KD and PFAPA may represent a genetic predisposition to dysregulated innate immune response.",
author = "Takahito Ninomiya and Hidetoshi Takada and Yusaku Nagatomo and Etsuro Nanishi and Hazumu Nagata and Kenichiro Yamamura and Takehiko Doi and Kazuyuki Ikeda and Toshiro Hara",
year = "2013",
month = "1",
day = "1",
doi = "10.1111/ped.12225",
language = "English",
volume = "55",
pages = "801--802",
journal = "Pediatrics International",
issn = "1328-8067",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Development of Kawasaki disease in a patient with PFAPA

AU - Ninomiya, Takahito

AU - Takada, Hidetoshi

AU - Nagatomo, Yusaku

AU - Nanishi, Etsuro

AU - Nagata, Hazumu

AU - Yamamura, Kenichiro

AU - Doi, Takehiko

AU - Ikeda, Kazuyuki

AU - Hara, Toshiro

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA) is one of the autoinflammatory diseases of unknown etiology characterized by regularly recurrent fever episodes with attacks lasting 3-6 days every 3-8 weeks associated with at least one of the three cardinal clinical signs: aphthous stomatitis, pharyngitis, and cervical adenitis. Kawasaki disease (KD) is an acute, self-limited systemic vasculitis that occurs predominantly in infants and young children. In most KD patients, i.v. immunoglobulin leads to a rapid amelioration of clinical symptoms and significantly decreases the risk of coronary artery aneurysms. Although the etiology of KD is still unknown, it was reported that innate immunity was activated in the patients. Described herein is a patient with PFAPA who developed KD. This is the first report of KD development in a PFAPA patient. The association between KD and PFAPA may represent a genetic predisposition to dysregulated innate immune response.

AB - Periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA) is one of the autoinflammatory diseases of unknown etiology characterized by regularly recurrent fever episodes with attacks lasting 3-6 days every 3-8 weeks associated with at least one of the three cardinal clinical signs: aphthous stomatitis, pharyngitis, and cervical adenitis. Kawasaki disease (KD) is an acute, self-limited systemic vasculitis that occurs predominantly in infants and young children. In most KD patients, i.v. immunoglobulin leads to a rapid amelioration of clinical symptoms and significantly decreases the risk of coronary artery aneurysms. Although the etiology of KD is still unknown, it was reported that innate immunity was activated in the patients. Described herein is a patient with PFAPA who developed KD. This is the first report of KD development in a PFAPA patient. The association between KD and PFAPA may represent a genetic predisposition to dysregulated innate immune response.

UR - http://www.scopus.com/inward/record.url?scp=84890463528&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890463528&partnerID=8YFLogxK

U2 - 10.1111/ped.12225

DO - 10.1111/ped.12225

M3 - Article

C2 - 24330294

AN - SCOPUS:84890463528

VL - 55

SP - 801

EP - 802

JO - Pediatrics International

JF - Pediatrics International

SN - 1328-8067

IS - 6

ER -